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LRRK2 is a kinase mutated in Parkinson’s disease,
but how the protein affects synaptic function remains
enigmatic. We identified LRRK2 as a critical regula-
tor of EndophilinA. Using genetic and biochemical
studies involving Lrrk loss-of-function mutants and
Parkinson-related LRRK2G2019S gain-of-kinase func-
tion, we show that LRRK2 affects synaptic endocy-
tosis by phosphorylating EndoA at S75, a residue in
the BAR domain. We show that LRRK2-mediated
EndoA phosphorylation has profound effects on
EndoA-dependent membrane tubulation and mem-
brane association in vitro and in vivo and on synaptic
vesicle endocytosis at Drosophila neuromuscular
junctions in vivo. Our work uncovers a regulatory
mechanism that indicates that reduced LRRK2
kinase activity facilitates EndoA membrane associa-
tion, while increased kinase activity inhibits mem-
brane association. Consequently, both too much
and too little LRRK2-dependent EndoA phosphoryla-
tion impedes synaptic endocytosis, and we propose
a model in which LRRK2 kinase activity is part of an
EndoA phosphorylation cycle that facilitates efficient
vesicle formation at synapses.
INTRODUCTION
Imbalances in synaptic transmission have been implicated in
Parkinson’s disease (PD) (Esposito et al., 2012; Plowey and
Chu, 2011); however, the underlying molecular mechanisms
remain unexplained. EndophilinA (EndoA) is an evolutionary
conserved protein critically involved in synaptic vesicle endocy-
tosis (Ringstad et al., 1997). EndoA harbors a Bin/Amphiphysin/
Rvs (BAR) domain that interacts with membranes and contains1008 Neuron 75, 1008–1021, September 20, 2012 ª2012 Elsevier Incspecial helices that, upon membrane insertion, are thought to
induce membrane deformation (Farsad et al., 2001; Gallop
et al., 2006). In vitro, EndoA tubulates membranes, while in vivo
EndoA is thought to drive vesicle formation by sensing or induc-
ing membrane curvature (Gallop et al., 2006; Masuda et al.,
2006) and facilitating vesicle uncoating (Milosevic et al., 2011;
Verstreken et al., 2002). Consequently, loss of EndoA function
results in very severe defects in synaptic vesicle endocytosis in
different species (Gadet al., 2000;Milosevic et al., 2011; Schuske
et al., 2003; Verstreken et al., 2002). Thus, EndoA is a critical
component of the endocytic machinery and is therefore ideally
posed to serve as a regulatory hub in the endocytic process.
Here we identify EndophilinA as a substrate of leucine-rich
repeat kinase 2 (LRRK2), a protein mutated in PD, and we show
that EndoAS75 phosphorylation is increased when expressing
the kinase-active clinical mutant LRRK2G2019S (Paisa´n-Ruı´z
et al., 2004; Zimprich et al., 2004) and strongly decreased in
Lrrk mutants (Lee et al., 2007). Increased EndoAS75 phos-
phorylation inhibits EndoA-dependent membrane tubulation
and decreases EndoA membrane affinity in vitro and in vivo. In
addition, expression of phosphomimetic EndoA or expression
of LRRK2G2019S impedes synaptic endocytosis. Conversely, re-
duced EndoAS75 phosphorylation in Lrrk mutants increases
EndoA membrane affinity, and expressing phosphodead EndoA
or Lrrk mutations also inhibits endocytosis, a defect rescued by
heterozygous endoA. Consistently, at moderate concentrations,
the LRRK2 kinase-inhibitor LRRK2-IN1 restores endocytosis in
LRRK2G2019S-expressing animals, while at higher concentrations
it blocks endocytosis to the level seen in Lrrk mutants. Thus,
LRRK-dependent EndoAS75 phosphorylation regulates EndoA
membrane affinity and both increased and decreased LRRK2
kinase activity inhibits synaptic endocytosis.
RESULTS
Slowed Synaptic Vesicle Endocytosis in LrrkMutants
Drosophila LRRK is present at synapses and associates
with membranes (Lee et al., 2010) and based on knockdown.
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LRRK2 Phosphorylates EndoA in Endocytosisexperiments in hippocampal neurons, LRRK2 has been impli-
cated in regulating synaptic vesicle trafficking (Piccoli et al.,
2011; Shin et al., 2008). To determine whether, in Drosophila,
LRRK is involved in synaptic vesicle endocytosis, we measured
neurotransmitter release in high external calcium using current-
clamp recordings at third-instar larval neuromuscular junctions
(NMJs) in Lrrk loss-of-function mutants (Lee et al., 2007). While
the amplitude of the excitatory junctional potential (EJP) re-
corded from Lrrk mutants at low-frequency stimulation in 2 mM
external calcium does not show a difference compared to con-
trols (see Figure S1A available online), Lrrk mutants fail to main-
tain release during intense (10 Hz) stimulation in 2 mM calcium,
a defect often observed inmutants with reduced synaptic vesicle
endocytosis (Figures 1A and 1B).
Testing further for a defect in synaptic vesicle formation in Lrrk
mutants, we used FM1-43 labeling at third-instar NMJs. FM1-43
is a lipophilic dye that becomes fluorescent when inserted in the
membrane and is internalized into newly formed synaptic vesi-
cles upon nerve stimulation. Using different stimulation para-
digms in the presence of FM1-43, Lrrk mutants show reduced
dye uptake compared to controls (Figures 1C–1F). This defect
is not caused by reduced vesicle fusion during stimulation, as
FM1-43 loaded during a 5 min, 90 mM KCl stimulation paradigm
is unloaded as efficiently from Lrrk mutant boutons as it is from
control boutons when stimulated using either 90 mM KCl (Fig-
ure 1G) or 10 Hz nerve stimulation (Figure S1B; rate constant,
control: 0.430 ± 0.058 min1; Lrrk: 0.509 ± 0.064 min1), again
indicating that, under these conditions, vesicle fusion per se is
not majorly affected in Lrrkmutants. The defect in FM1-43 inter-
nalization is also not caused by major morphological changes at
the NMJ, as synapse length and large type 1b bouton number
are not affected in Lrrk mutants compared to controls (Figures
S1C and S1D). Finally, the defect in FM1-43 internalization is
also specific to loss of Lrrk function, as a different heteroallelic
combination (LrrkP1/LrrkEX2) displays an identical defect to inter-
nalize FM1-43 compared to LrrkP1 (Figure 1D), and furthermore,
expression of human LRRK2 in LrrkP1mutants rescues the FM1-
43 dye uptake phenotype (Figure 1E), indicating evolutionary
conservation of this function of LRRK2.
To also assess the ultrastructure of Lrrk mutant boutons, we
performed transmission electron microscopy (TEM) of stimu-
lated NMJ boutons. In contrast to control boutons, we observe
an increased density of cisternal structures and larger vesicles
at the expense of normal-sized synaptic vesicles in Lrrk mutant
boutons (Figures 1H–1L). Our data also suggest these cisternae
in Lrrk mutants can fuse with the membrane and release trans-
mitters, as miniature EJP (mEJP) amplitude in Lrrk mutants is
markedly increased compared to controls (Figures 1M–1O; Fig-
ure S1E). Larger amplitude mEJPs may be due to more neuro-
transmitters being released from presynaptic vesicles or also
because of a more elaborate glutamate receptor field; however,
the postsynaptic glutamate receptor field in Lrrk mutants does
not appear different from controls at the level of immunohisto-
chemistry (Figure S1F), suggesting that the defect in mEJP
amplitude in Lrrk mutants originates presynaptically. An in-
creased number of cisternae are often observed in mild endo-
cytic mutants, including hypomorphic endophilinA (endoA) (Gui-
chet et al., 2002), dap160 (Koh et al., 2004), AP180/lap (ZhangNeuet al., 1998), eps15 (Koh et al., 2007), and stnB (Fergestad
et al., 1999) mutants. The cisternal defect is thought to arise
from a slowed and inefficient endocytic machine that fails to
form vesicles of defined size. Hence, the data are consistent
with slowed synaptic vesicle recycling in Lrrk mutants.
Lrrk Mutants Are Rescued by Heterozygous endoA
To start exploring the potential function for LRRK in vesicle recy-
cling, we quantified synaptic vesicle formation in Lrrk mutants
heterozygous for different components involved in clathrin-
mediated synaptic vesicle endocytosis. While heterozygosity
for clathrin heavy chain (chc), AP180 (lap), alpha adaptin
(a-ada), eps-15, and dap160/intersectin (dap160) in Lrrkmutants
does not affect FM1-43 dye uptake, loss of one copy of endoA in
Lrrk mutants completely rescues the FM1-43 dye uptake defect
observed in Lrrk mutants back to control levels (Figure 2A). This
effect is specific to the loss of one copy of endoA, because
crossing a genomic rescue construct that expresses the wild-
type endoA gene (endoA+) at endogenous levels, into Lrrk
mutants that are heterozygous mutant for endoA, shows
FM1-43 dye uptake defects akin to Lrrk mutants (Figure 2A). In
contrast to loss of endoA rescuing the endocytic defect in Lrrk
mutants, overexpressing EndoA using an upstream activating
sequence (UAS)-EndoA transgene (Jung et al., 2010) and the
Elav-Gal4 neuronal driver in Lrrk mutants exacerbates the
FM1-43 dye uptake defect that we observed in Lrrkmutants (Fig-
ure 2B). Note that overexpression of EndoA alone does not show
a defect in FM1-43 dye uptake. Thus, EndoA is a dosage-sensi-
tive modifier of Lrrk in Drosophila.
To further test the effect of endoA on the suppression of Lrrk-
dependent phenotypes, we also measured neurotransmitter
release during 10 Hz stimulation in Lrrk mutants that are hetero-
zygous for endoA. We find that Lrrk mutants with only one copy
of endoA are very similar to controls in this assay (Figure 2C).
Finally, we also measured the ability of Lrrk mutants and Lrrk
mutants heterozygous for endoA to resist stress at high temper-
ature. In this assay, we placed the flies in a tube in a water bath
at 38C and counted the flies climbing on the wall within a 1 hr
time interval. Lrrk mutant flies drop faster than controls, and
also this defect is rescued by heterozygous endoA. Again,
crossing endoA+ into Lrrkmutants that are heterozygous mutant
for endoA shows a defect very similar to Lrrk (Figure S2). Hence,
heterozygous loss of endoA suppresses numerous deficits ob-
served in Lrrk mutants.
LRRK2 Phosphorylates EndoA at Serine 75
Given the genetic interaction between Lrrk and endoA, we tested
whether human LRRK2 or Drosophila LRRK can phosphorylate
EndoA in vitro using purified proteins in a 33P-ATP phosphoryla-
tion assay. Incubation of human LRRK2 with human EndoA1–
EndoA3 indicates efficient EndoA1–EndoA3 phosphorylation
by LRRK2 (Figures 3A–3C0). Adding kinase-hyperactive clinical
LRRK2G2019S mutant results in faster and more efficient EndoA1
phosphorylation, while adding kinase-dead mutant LRRK2 does
not show appreciable EndoA1–EndoA3 phosphorylation. Simi-
larly, a Drosophila LRRK-enriched fraction, as well as human
LRRK2 and LRRK2G2019S, is able to efficiently phosphory-
late tandem affinity-purified Drosophila Flag-strep-EndoA. Inron 75, 1008–1021, September 20, 2012 ª2012 Elsevier Inc. 1009
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tandemaffinity-purifiedDrosophila Flag-strep-EndoA (Figure 3D,
Figure S3C). Conversely, another Parkinson’s disease-related
kinase, GSK3b (Lin et al., 2010), is not able to phosphorylate
EndoA1 in vitro (data not shown). Thus, the data indicate that
EndoA is a target of LRRK and LRRK2 kinase activity in vitro.
To identify the EndoA1 amino acid(s) targeted by LRRK2
activity, we used mass spectrometry (MS). In vitro phosphory-
lated EndoA1 was separated from other proteins by SDS-PAGE
and the EndoA1 band was in-gel digested with trypsin. Samples
were then separated using liquid chromatography and spectra
obtained via an Orbitrap MS/MS were identified with the
MASCOT search algorithm in the SwissProt database. At 86%
EndoA1 sequence coverage (Figure S3A), our analyses identified
oneconservedsite, serine75 (S75)at 99%confidence,asa target
of LRRK2-dependent phosphorylation. Also after independent
enrichment of phosphopeptides using titanium dioxide, we iden-
tified S75 as an LRRK2 phosphorylation site. This site is specific,
as we did not identify S75 to be phosphorylated when incubating
EndoAwith LRRK2KD (FigureS3B). EndoA1S75 iswell conserved
across species (Figure 3E), implying functional significance.
To also test whether LRRK2 mediates EndoA1 phosphoryla-
tion in cells, we expressed LRRK2 and EndoA1 in CHO cells
and incubated them in 33P-ATP. Immunoprecipitation of EndoA1
andautoradiography indicate that EndoA1phosphorylation upon
expression of LRRK2 is clearly increased above the basal phos-
phorylation (Figures 4A and 4B, first two lanes). Furthermore, we
find a significant increase in EndoA1 phosphorylation upon
expression of LRRK2G2019S (third lane) compared to expression
of green fluorescent protein (GFP), but not upon expression of
LRRK2KD (fourth lane). EndoA1 harborsmultiple phosphorylation
sites (Kjaerulff et al., 2011), and to determine the contribution of
LRRK2 to the basal EndoA1 phosphorylation level, we generated
a stably transfected LRRK2 shRNA-expressingCHOcell linewith
strongly reduced LRRK2 expression levels (Figures S4A and
S4B). We find that in these shRNA-expressing cells, EndoA1
phosphorylation is reduced to a level significantly lower than
the basal level of EndoA1 phosphorylation. Similarly, LRRK2
shRNA also efficiently knocks down coexpressed LRRK2G2019SFigure 1. Loss of Lrrk in Drosophila Causes Mild Defects in Synaptic V
(A) Neurotransmission in 2 mM calcium during 10 min of 10 Hz stimulation in cont
normalized to the average amplitude of the first 15 s. Average EJP amplitude in Lrr
(t test: p < 0.001). Related to Figure S1.
(B) Raw data traces of EJPs recorded for 10 min at 10 Hz in 2 mM calcium. The
(C–F) Images of FM1-43 labeling (C) and quantification of intensity (D–F) in control
in D), as well as in Lrrk mutants expressing wild-type human LRRK2 (w/Act
hLRRK2D2017A/+;LrrkP1 in E) NMJ boutons in L3 fillets using 1 min, 90 mM KCl stim
labels the reserve pool (RP) (F); FM1-43 loading in 10 min of 10 Hz stimulation in
90 mM KCl without FM1-43. Error bars represent SEM. n > 9, t test: **p < 0.01; *
(G) Quantification of FM1-43 labeling intensity after a loading and unloading pro
90 mM KCl in FM1-43, washed, and imaged and then unloaded using 1 min, 90 m
loss compared to the labeled boutons is shown. An unloading time course is sho
(H–L) Electron micrographs of control (H) and LrrkP1mutant (I and J) boutons stim
vesicle number (<80 nm diameter) per area (K) or cisternal number (>80 nm diam
T-bar number are not different (data not shown). Scale bar represents 250 nm in
animals, t test: ns, (p = 0.06), ***p < 0.001.
(M–O) Sample traces of spontaneous vesicle fusion (mEJPs) events recorded in
amplitudes (control 2,481 and LrrkP1 2,822 events) (N), and quantification of the m
n > 8 animals, t test: *p < 0.05. Related to Figure S1.
Neu(or LRRK2KD) (Figures S4C and S4D), resulting in significantly
lower EndoA1 phosphorylation (Figures 4A and 4B). Thus,
EndoA1 is an LRRK2 substrate in a cellular context as well.
Next, we generated phospho-S75 antibodies to Drosophila
EndoA (Ab-EndoS75). First, we tested the specificity of these anti-
bodies and created endoA null mutantDrosophila (endoAD4) that
harbors a genomic endoA+, endoA[S75A], endoA[S75D], or
endoA[S75E] transgene. The transgenes were inserted in the
same genomic location (VK37, cytology 22A3), ensuring similar
EndoA expression under native promoter control. Western
blotting using Ab-EndoS75 indicates a weak 42 kDa band in
wild-type Drosophila extract and in endoA[S75A]/+; endoAD4
that is much more prominent in endoA[S75D]/+; endoAD4 or in
endoA[S75E]/+; endoAD4, indicating Ab-EndoS75 preferentially
recognizes an epitope in EndoA that is similar to a phosphomi-
metic mutation at S75 (Figure 4C). Next, we tested Lrrk mutant
and control Drosophila extracts and probed western blots with
Ab-EndoS75 and Ab-EndoAGP69 that recognize Drosophila
EndoA (Verstreken et al., 2002). Compared to controls, Lrrk
mutants show reduced Ab-EndoS75 immunoreactivity to a level
similar to that seen in Lrrk or control samples in which proteins
were dephosphorylated with lambda phosphatase (Figures 4D
and 4E). Next, we generated transgenic Drosophila expressing
the kinase-active clinical mutant LRRK2G2019S and kinase-
dead LRRK2KD under control of the UAS/Gal4 system.
Compared to expression of LRRK2KD, we find a more than
2-fold increase in Ab-EndoS75 signal upon expression of the
kinase-active LRRK2G2019S (Figures 4F and 4G). These data indi-
cate that LRRK/LRRK2 kinase activity is necessary and sufficient
for EndoA S75 phosphorylation in vivo.
EndoA Phosphorylation Inhibits Membrane Tubulation
To test whether phosphorylation of S75 affects EndoA function,
we performed in vitro tubulation assays. We mixed purified
Drosophila Flag-EndoA as well as Flag-EndoA[S75A], Flag-En-
doA[S75D], or Flag-EndoA[S75E] with DiO-labeled giant unila-
mellar vesicles (GUVs; 10–100 mm diameter) and assessed
membrane tubulation using confocal microscopy. While EndoA
or the phosphodead EndoA[S75A] both extensively tubulateesicle Endocytosis
rol (w1118) and Lrrkmutants (w; LrrkP1). EJP amplitudes are binned per 30 s and
kP1mutants in the last 3min of recording is 84.7%± 6.1%compared to controls
gray traces behind the Lrrk data are the control data shown for comparison.
(w1118 in D orw;Act-Gal4 in E), Lrrkmutant (w; LrrkP1 in C–F andw; LrrkP1/Lrrkex1
-Gal4;UAS-hLRRK2/+;LrrkP1 in E) or LRRK2 kinase-dead (w/Act-Gal4;UAS-
ulation to label the exo-endo cycling pool (ECP) (C–E) or using a protocol that
2 mM Ca2+; 5 min no stimulation; wash in HL-3 and unload ECP using 5 min,
**p < 0.001.
tocol of control and LrrkP1 mutant synapses. NMJs were loaded using 5 min,
M KCl in the absence of FM1-43, washed, and imaged again. The percent dye
wn in Figure S1. Error bars represent SEM, n > 5, t test: ns, not significant.
ulated using 60 mM KCl for 1 min prior to fixation and quantification of synaptic
eter) per area (L). Other synaptic features including mitochondrial number or
(H) and 500 nm in (I). Error bars represent SEM, n > 10 profiles from at least 4
HL-3 with 0.5 mM Ca2+ and TTX (M), cumulative probability plots of the mEJP
EJP amplitude in control and in LrrkP1 mutants (O). Error bars represent SEM,
ron 75, 1008–1021, September 20, 2012 ª2012 Elsevier Inc. 1011
Figure 2. Heterozygous Loss of EndoA Suppresses Lrrk Mutant
Phenotypes
(A) Quantification of FM1-43 labeling intensity after a 1 min, 90 mM KCl
stimulation protocol in control (w1118, green), in Lrrkmutants (w; LrrkP1), in Lrrk
mutants heterozygous for endoA (w; LrrkP1/LrrkP1endoAD4, red), in Lrrk
mutants heterozygous for endoA and carrying a genomic endoA rescue
construct (w; endoA+/+; LrrkP1/LrrkP1 endoAD4), and in Lrrk mutants hetero-
zygous for different endocytic genes (w chc1/w; LrrkP1,w; LrrkP1/LrrkP1 lap1,w;
eps15e75/+;LrrkP1, w; ada1 /+;LrrkP1, w; dap160D2/+;LrrkP1). Error bars repre-
sent SEM, n = 5–18 animals, t test: ***p < 0.001, ns.
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[S75D] or EndoA[S75E] fail to do so (Figures 5D, 5H, and 5K0),
suggesting that phosphorylation of S75 inhibits membrane tubu-
lation in vitro. To determine whether this effect is due to LRRK2-
dependent phosphorylation, we phosphorylated EndoA in vitro
using LRRK2 and ATP and then incubated the proteins with
GUVs. In contrast to nonphosphorylated EndoA, LRRK2-phos-
phorylated EndoA does not induce GUV tubulation (Figures 5E,
5F, and 5K00). This effect is specific to LRRK2-dependent EndoA
phosphorylation at S75, because incubation of GUVs with phos-
phodead EndoA[S75A] that was treated with LRRK2 and ATP
results in efficient tubulation (Figures 5G and 5K00). These data
indicate that LRRK2-dependent EndoA S75 phosphorylation
inhibits membrane tubulation in vitro.
To understand the functional significance of EndoA S75
phosphorylation, we modeled the three-dimensional structure
of Drosophila EndoA using the X-ray crystal coordinates of
human EndoA (Weissenhorn, 2005) (PDB2Z0V). Interestingly,
Drosophila EndoA S75 is located in the BAR domain at the tip
of the helix1 appendage and we propose that, similar to
mammalian EndoA1 (Jao et al., 2010), EndoA S75 also associ-
ates with the membrane (Figures 5I and 5J). Given that phos-
phorylation at S75 introduces a negative charge, we tested
whether this modification affects membrane association of
EndoA using liposome flotation assays (Figures 5K0 and 5L).
We mixed purified Flag-tagged EndoA, EndoA[S75A], and
EndoA[S75D] with liposomes and separated lipid-bound pro-
tein from unbound protein using a Nycodenz gradient. While
EndoA or Endo[S75A] consistently associate with liposomes,
EndoA[S75D] does not (Figures 5K0 and 5L), indicating that
EndoA S75 phosphorylation inhibits membrane association. To
determine whether EndoA membrane association is regulated
by LRRK2-dependent phosphorylation, we preincubated EndoA
with LRRK2 and ATP and found that phosphorylation of EndoA
by LRRK2 impedes membrane binding (Figure 5K00). Conversely,
phosphodead Endo[S75A] preincubated with LRRK2 and ATP
still associates with liposomes (Figure 5K00). Thus, phosphoryla-
tion of EndoA at S75 is an important determinant of EndoA
membrane association in vitro.
Finally, we tested whether LRRK2 can influence membrane
association of EndoA that is already bound to liposomes.
We therefore preincubated EndoA with liposomes and only(B) Quantification of FM1-43 labeling intensity after a 1 min, 90 mM KCl
stimulation protocol in control (w/Elav-Gal4) and in animals neuronally over-
expressing EndoA (w/Elav-Gal4; UAS-endoA), in Lrrk mutants (w/Elav-Gal4;
LrrkP1), and in Lrrk mutants neuronally overexpressing EndoA (w/Elav-Gal4;
UAS-endoA; LrrkP1). Error bars represent SEM, n = 3–5 animals, t test: *p <
0.05, **p < 0.01; ns.
(C) Neurotransmitter releasemeasured in 2mM calcium during 10min of 10 Hz
stimulation in heterozygous endoA larval fillets (w; endoAD4/+) and in Lrrk
mutants heterozygous for endoA (w; LrrkP1/LrrkP1 endoAD4). EJP amplitudes
are binned per 30 s and normalized to the average amplitude of the first 30 s.
Data recorded from controls (w1118) and Lrrkmutants (shown in Figure 1A) are
shown for comparison. The average EJP amplitude inw; endoAD4/+ in the last
3min of recording is 98.4%± 5.5%ofw1118 controls (t test: not significant). The
average EJP amplitude in w; LrrkP1/LrrkP1 endoAD4 in the last 3 min of
recording is 103.7% ± 4.3% of w1118 controls versus 84.7% ± 6.1% in LrrkP1
(t test: p < 0.001).
.
Figure 3. LRRK2 Phosphorylates EndoA at Serine 75 In Vitro
(A–D) Autoradiographs (uneven rows) and total protein (even rows) of in vitro kinase reactions using wild-type human LRRK2WT, kinase-active LRRK2G2019S, or
kinase-dead LRRK2KD and human EndoA1–EndoA3 (A, B, and C) as substrate during indicated time points and quantification of 33P incorporation in human
EndoA (A0, B0, and C0) or in a Drosophila EndoA-enriched fraction (D) normalized to the 33P incorporation in wild-type LRRK2 at the 120 min time point (100%).
Error bars represent SEM, n = 3 independent experiments and data means fitted using GraphPad.
(E) Alignment of human, mouse EndoA1, EndoA2, and EndoA3, nematode UNC-57, and fruit fly EndoA around the S75 phosphorylation site (red) identified by
mass spectrometry. Related to Figure S3.
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LRRK2 Phosphorylates EndoA in Endocytosisthen added LRRK2 or the kinase-active LRRK2G2019S mutant
and ATP. Flotation assays indicate that both LRRK2 and
LRRK2G2019S are very efficient at dissociating EndoA from lipo-
somes, and most EndoA is found in the unbound fraction
(Figures 5K00 0 and 5M). This effect is specific to LRRK2 kinase
activity, as adding kinase-dead LRRK2KD and ATP fails to disso-
ciate EndoA bound to liposomes (Figures 5K00 0 and 5M). Thus,
our data indicate that LRRK2 can operate at the membrane to
facilitate the displacement of EndoA from the membrane.
LRRK Impedes EndoA Membrane Association In Vivo
To determine whether LRRK affects EndoA membrane associa-
tion in vivo, we fractionated control, Lrrk mutant, LRRK2G2019S-,Neuand kinase-dead LRRK2KD-expressing fly heads and probed
cytosolic and membrane fractions with Ab-EndoAGP69 anti-
bodies. We used Drosophila antineuronal Synaptobrevin (Ab-
Nsyb) to assess the purity of our membrane fraction. Compared
to control, we find an almost 2-fold increase of EndoA in the
membrane fraction of Lrrkmutants (Figures 6A–6C). Conversely,
EndoA distribution in the membrane fraction is reduced upon
expression of kinase-active LRRK2G2019S compared to fractions
prepared from controls or from flies expressing LRRK2KD (Fig-
ures 6D–6F). Similarly, also in CHO cells that express LRRK2
shRNA, significantly more EndoA accumulates in the membrane
fraction (Figures S5A and S5B), while in CHO cells that express
LRRK2G2019S or wild-type LRRK2, significantly less EndoA isron 75, 1008–1021, September 20, 2012 ª2012 Elsevier Inc. 1013
Figure 4. EndoA1/EndoA Is Phosphorylated
by LRRK2/LRRK in Cells and Flies
(A and B) Autoradiogram and western blot probed
with anti-Flag (recognizing Flag-tagged EndoA1)
of EndoA1 immunoprecipitates (anti-Flag) of 33P-
metabolic-labeled CHO cells stably transfected
with a control scrambled shRNA (left, green) or
with an shRNA targeting LRRK2 (right, purple)
(related to Figure S4) and also double transfected
with Flag-tagged human EndoA1 and with GFP
as negative control, with LRRK2WT (wild-type),
with LRRK2G2019S (kinase hyperactive), or with
LRRK2KD (kinase dead) (A), and quantification of
incorporated 33P in immunoprecipitated EndoA1
(B) normalized to 33P incorporation in EndoA1 in
GFP-transfected and scrambeled shRNA-trans-
fected cells (GFP and scrambled shRNA, 100%).
Error bars represent SEM, n = 3 independent
experiments. ANOVA and Dunnett’s post hoc:
*p < 0.05.
(C)Westernblots of fly headextracts fromendoAD4
Drosophilamutants expressing a genomic endoA+
construct (w; endoA+/+; endoAD4), phosphodead
EndoA (w; endoA[S75A]/+; endoD4), or a phos-
phomimetic EndoA (w; endo[S75D]/+; endoD4 or
w; endo[S75E]/+; endoD4) using antibodies to
phosphorylated S75 in Drosophila EndoA (Ab-
EndoAS75) and using antibodies to totalDrosophila
EndoA (Ab-EndoAGP69).
(D and E) Western blots of fly head extracts
from control (w1118) and Lrrk mutants (w; LrrkP1)
and extracts from control and Lrrk mutants that
were dephosphorylated using lambda phospha-
tase and probed with the antibodies Ab-
EndoAS75 and with Ab-EndoAGP69 and Ab-
Tubulin (D). Quantification of labeling intensity of
Ab-EndoAS75 was normalized to Ab-EndoAGP69
and value of dephosphorylated samples were
subtracted (E). Error bars represent SEM, n = 4,
t test: **p < 0.01.
(F and G) Western blots of fly head extracts
from flies expressing V5-tagged kinase-dead
LRRK2KD (yw; Act-Gal4/LRRK2D2017A) and V5-
tagged kinase-active LRRK2G2019S (yw; Act-Gal4/
LRRK2G2019S), as well as lambda-dephosphory-
lated extracts probed with the Ab-V5, Ab-
EndoAS75, Ab-EndoAGP69, and Ab-Tubulin (F). Quantification of labeling intensity of Ab-EndoAS75 was normalized to Ab-EndoAGP69 and value of dephos-
phorylated samples was subtracted (G). Error bars represent SEM, n = 3, t test: *p < 0.05.
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LRRK2 Phosphorylates EndoA in Endocytosispresent in the membrane fraction compared to cells expressing
kinase-dead LRRK2KD (Figures S5C and S5D). Thus, in line with
our in vitro results, both in flies and in mammalian cells, loss of
Lrrk/LRRK2 function results in increased association of EndoA
with membrane, whereas gain-of-LRRK2 kinase activity im-
pedes EndoA membrane association.
Phosphodead and Phosphomimetic EndoA Inhibit
Endocytosis
Our results thus far allow us to make a number of predictions.
First, given that inhibition of EndoA S75 phosphorylation facili-
tates membrane association, we expect flies expressing a
phosphodead EndoA to harbor too much membrane-bound
EndoA that impedes the endocytic process, similar to our
observations in Lrrkmutants. Second, phosphorylation of EndoA1014 Neuron 75, 1008–1021, September 20, 2012 ª2012 Elsevier IncS75 inhibits membrane association of the protein and flies
expressing a phosphomimetic EndoA are therefore predicted
to also show reduced endocytosis. Third, because EndoA
S75 phosphorylation in animals that express the kinase-active
LRRK2G2019S is increased, we also expect this condition to
show reduced endocytosis. Fourth, we surmise that a specific
LRRK2 kinase inhibitor will result in endocytic defects similar to
Lrrk mutants and that this inhibitor does not exacerbate the en-
docytic defects in phosphodead EndoA but that it rescues the
endocytic defects in LRRK2G2019S-expressing animals.
To start testing these predictions, we expressed EndoA
[S75A] and EndoA[S75D] using genomic fragments in endoAD4
null mutants (Figure S6A) and determined endocytic efficiency.
First, we stimulated larval fillets for 1 min in 90 mM KCl with
FM1-43. Compared to endoA+/+; endoAD4 control third-instar.
Figure 5. LRRK2-Mediated EndoAS75
Phosphorylation Inhibits Membrane Tubu-
lation and Membrane Association
(A–H) Tubulation assays using DiO-labeled giant
unilamellar vesicles (GUVs) after incubation with
buffer (A), Drosophila EndoA (B), phosphodead
Drosophila EndoA[S75A] (C), phosphomimetic
Drosophila EndoA[S75D] or EndoA[S75E] (D
and H), with human LRRK2 and ATP (E), with
Drosophila EndoA preincubated with human
LRRK2 and ATP (F), or with Drosophila EndoA
[S75A] preincubated with human LRRK2 and ATP
(G). Data also tabulated in left columns in (K0) and
(K00). Scale bar represents 40 mm.
(I and J) Three-dimensional model of a Drosophila
EndoA dimer highlights the location of S75 in the
BAR domain. Side view of a Drosophila EndoA
dimer with helix1 appendages in green onto a lipid
bilayer (I) is shown. A 90 tilt view of an EndoA
dimer on a lipid bilayer (J) is shown.
(K–M) Assessment of tubulation activity toward
GUVs (K, left column) using protein samples
shown in (A)–(D) in (K0) and using protein samples
shown in (E)–(G) in (K00). Liposome membrane
binding ability of different EndoA proteins (EndoA,
EndoA[S75A], and EndoA[S75D]) in flotation
assays (L and K0, right column), LRRK2, and
EndoA or EndoA[S75A] incubated with LRRK2 and
ATP prior to incubation with liposomes (K00, right
column), and EndoA first incubated with lipo-
somes and only then with LRRK2 (LRRK2WT),
G2019S (LRRK2G2019S), or KD (LRRK2D1994A) and
ATP (M and K00 0, right column). EndoA was de-
tected using Ab-FlagM2. Binding percentage right
column in (K) was quantified as the intensity in the
top two fractions (1 and 2) compared to the total
labeling in all fractions (1–6). n = at least 3 inde-
pendent blind repeats.
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LRRK2 Phosphorylates EndoA in Endocytosislarvae, both the endoAD4 animals that express the EndoA[S75A]
phosphodead mutant, as well as the endoAD4 animals that
express the EndoA[S75D] phosphomimetic mutant, show
reduced synaptic vesicle endocytosis (Figures 7A–7D). Our
data indicate that both phosphorylation and dephosphory-
lation of EndoA at S75 inhibit FM1-43 dye uptake at synapses
in vivo.
To further test our predictions, we also used an independent
pharmacological approach to inactivate LRRK2 activity. We
incubated dissected control third-instar larval fillets for 30 min
with different concentrations of LRRK2-IN-1, an LRRK2 inhibitor
(Deng et al., 2011), and determined synaptic endocytosis using
FM1-43. Application of LRRK2-IN-1 results in a dose-dependentNeuron 75, 1008–1021, Sepreduction in FM1-43 dye uptake (Fig-
ure S6B). Furthermore, defects in FM1-
43 dye uptake are very similar in Lrrk
mutants or in Lrrk mutants incubated
with the inhibitor (Figure S6C), indicating
specificity of LRRK2-IN-1 to LRRK-
dependent synaptic membrane uptake
defects. In addition, LRRK2-IN-1-medi-
ated inhibition of LRRK in animals thatonly express the phosphodead EndoA does not significantly
exacerbate their FM1-43 dye uptake defect (Figure S6D). Hence,
reduced LRRK-dependent EndoAS75 phosphorylation results in
reduced synaptic vesicle formation during stimulation. A high
concentration of inhibitor is needed in these assays probably
because of limited penetration into the Drosophila larval NMJ
(Miskiewicz et al., 2011; Pawlu et al., 2004). It should be noted
that the specificity of the effect is controlled in Figures S6C
and S6D, demonstrating that the defect in synaptic endocytosis
is critically dependent on the absence of LRRK and on the ability
of EndoA to be phosphorylated.
To assess whether the defects in FM1-43 dye uptake in the
EndoA S75 phosphomutants are the result of reduced synaptictember 20, 2012 ª2012 Elsevier Inc. 1015
Figure 6. LRRK Controls EndoA Membrane Association In Vivo
(A–C) Western blots of cytosol and membrane fractions of control (w1118) and
Lrrk mutant flies (w;LrrkP1) probed with Ab-Tubulin, Ab-EndoAGP69, and Ab-
NsybR29 (a membrane marker) revealing EndoA partitioning between
membrane (A) and cytosol (B) and quantification of the ratio of labeling
intensity of Ab-EndoAGP69 in the membrane fraction normalized to Ab-NsybR29
to the labeling intensity of Ab-EndoAGP69 in the cytosol fraction normalized to
Ab-Tubulin, normalized to control (C). Error bars represent SEM, n = 3 inde-
pendent experiments. t test: *p < 0.05.
(D–F) Western blots of cytosol and membrane fractions of control (yw;
da-Gal4/+) and flies expressing kinase-dead LRRK2KD (yw; da-Gal4/
LRRK2D2017A) or kinase-active LRRK2G2019S (yw; da-Gal4/LRRK2G2019S)
probed with Ab-Tubulin, Ab-EndoAGP69, and Ab-NsybR29 revealing EndoA
partitioning between membrane (D) and cytosol (E) and quantification of the
ratio of labeling intensity of Ab-EndoAGP69 in the membrane fraction normal-
ized to Ab-NsybR29 to the labeling intensity of Ab-EndoAGP69 in the cytosol
fraction normalized to Ab-Tubulin, normalized to control (F). Error bars
represent SEM, n = 4 independent experiments. ANOVA and Dunnett’s post
hoc: **p < 0.05. Related to Figure S5.
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LRRK2 Phosphorylates EndoA in Endocytosisvesicle endocytosis, we recorded EJPs during a 10 min of 10 Hz
stimulation paradigm; we analyzed boutonic ultrastructure and
we recorded mEJPs, assays that when performed on
Lrrk mutants show defects (Figure 1). Under conditions of
2 mM external calcium, endoA+/+; endoAD4 controls, as well
as endoA[S75A]/+; endoAD4 and endoA[S75D]/+; endoAD4,
show similar EJP amplitudes during low-frequency stimulation,
indicating normal synaptic transmission (Figure S6E). In addition,
FM1-43 internalized during a 5 min, 90 mMKCl stimulation para-
digm is efficiently unloaded during a second stimulation period in
both endoA+/+; endoAD4 controls and in animals expressing the
EndoA phosphomutants, indicating normal vesicle fusion under
these conditions (Figure S6F). However, both endoA[S75A]/+;
endoAD4 and endoA[S75D]/+; endoAD4 fail to maintain neuro-
transmitter release during 10 min of 10 Hz stimulation, while
endoA+/+; endoAD4 controls maintain release well (Figures 7E1016 Neuron 75, 1008–1021, September 20, 2012 ª2012 Elsevier Incand 7F). This defect is consistent with reduced synaptic vesicle
recycling in the EndoA phosphomutants.
Next, we performed TEM on stimulated third-instar larval bou-
tons. Very similar to endoA hypomorphic mutants (Guichet et al.,
2002), synaptic vesicle number in endoA[S75A]/+; endoAD4, as
well as in endoA[S75D]/+; endoAD4, is reduced and the
number of cisternae is significantly increased compared to
endoA+/+; endoAD4 controls (Figures 7G–7J). Our data also
suggest that the cisternae seen in endoA[S75A]/+; endoAD4
and endoA[S75D]/+; endoAD4 fuse with themembrane to release
transmitters, as we observe larger mEJP amplitudes in endoA
[S75A]/+; endoAD4 and in endoA[S75D]/+; endoAD4 but not in
endoA+/+; endoAD4 controls (Figure 7K and Figure S6G). These
defects are qualitatively similar to those observed in Lrrkmutants
(Figure 1) and collectively they suggest that animals expressing
the EndoA S75 phosphomutants harbor synaptic vesicle recy-
cling deficits that parallel the endocytic defect seen in endoA
hypomorphic mutants (Guichet et al., 2002).
LRRK2G2019S Impedes Synaptic Vesicle Endocytosis
If endoA[S75D]/+; endoAD4 animals display reduced synaptic
endocytosis, we expect expression of LRRK2G2019S that results
in increased EndoA S75 phosphorylation in vivo to also lead to
defects in synaptic vesicle endocytosis. We therefore performed
FM1-43 dye uptake experiments in Drosophila expressing the
kinase-active clinical mutant LRRK2G2019S. Similar to endoA
mutants that express EndoA[S75D], we find that expression of
LRRK2G2019S results in significantly reduced synaptic vesicle
endocytosis, while expression of the kinase-dead LRRK2KD
does not affect FM1-43 dye uptake (Figure 8A). If this deficit in
LRRK2G2019S-expressing Drosophila is caused by increased
kinase activity, we expect that application of LRRK2-IN1 can
alleviate the endocytic defect. Conversely, adding even higher
doses of LRRK2-IN1 should block both endogenous LRRK and
LRRK2G2019S and again impede endocytosis. As shown in Fig-
ure 8B, we find that the defect in synaptic vesicle endocytosis
upon application of LRRK2-IN1 to LRRK2G2019S-expressing
animals is rescued. Interestingly, further increasing the LRRK2-
IN1 concentration applied to LRRK2G2019S-expressing animals
again results in defects to internalize FM1-43 (Figure 8B). Taken
together, the data indicate that both increased and decreased
LRRK-dependent EndoA phosphorylation impedes synaptic
vesicle endocytosis (Figures 8C and 8D).
DISCUSSION
In this work, we show that EndoA is phosphorylated by LRRK2
and that this posttranslational modification modulates EndoA-
dependent membrane deformation in vitro and endocytosis
of synaptic membrane in vivo. Endocytosis is a dynamic process
that depends on numerous transient protein-protein and
protein-lipid interactions (Schmid et al., 2006; Tonikian et al.,
2009). Our data indicate that reduced S75 phosphorylation in
EndoA, although still supporting membrane tubulation in vitro,
acts negatively on synaptic recycling in vivo, because the
protein fails to efficiently leave the membrane (Figure 8D). In
line with this, a constitutive membrane-bound EndoA (Unc-57)
also does not fully rescue unc-57 C. elegans mutants (Bai.
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LRRK2 Phosphorylates EndoA in Endocytosiset al., 2010). In addition, overexpression of EndoA in Lrrk
mutants exacerbates synaptic vesicle endocytosis, while
heterozygous loss of endoA rescues Lrrk mutants. The data
suggest that excessive dephosphorylated EndoA in Lrrk flies is
‘‘locked’’ such that constitutive membrane binding of the protein
impedes the transient and vibrant interactions needed to create
new vesicles and/or to deliver the protein to endocytic zones
(Bai et al., 2010).
EndoA is also involved in recruiting Synaptojanin (Synj) to
nascent synaptic vesicles. Synj is a phosphoinositide phospha-
tase involved in uncoating of proteins from newly formed vesi-
cles, and endoA null mutant synapses display reduced levels
of Synj and an increased number of densely coated synaptic
vesicles (Milosevic et al., 2011; Schuske et al., 2003; Verstreken
et al., 2002). Given that it is difficult to discern coated from
uncoated vesicles in our TEM preparations of the EndoA S75
phosphomutants, we did not determine whether the amount
of densely coated vesicles is altered. However, we observe
reduced levels of the uncoating factor Synaptojanin in Lrrk
animals (unpublished data), suggesting that in the Lrrk flies late
stages of endocytosis may also be blocked. Further work is
needed to determine precisely how different aspects of EndoA
function are affected by LRRK. Nevertheless, LRRK-dependent
phosphorylation of EndoA in the helix1 appendage reduces
EndoA membrane affinity and this modification may force the
protein to leave nascent uncoated vesicles, driving new vesicle
formation (Figure 8C). Indeed, LRRK2 kinase is able to dissociate
EndoA from liposomes and we propose a model in which an S75
phosphorylation-dephosphorylation cycle controls EndoA func-
tion at the membrane to drive vesicle formation and uncoating at
the synapse (Figures 8C and 8D). Conceivably, LRRK is involved
in the efficient removal of postendocytic EndoA and its binding
partners from synaptic vesicles, allowing a new round of endocy-
tosis to occur.
Mutations in the LRRK2 gene are the leading cause of familial
PD, but the molecular mechanisms by which the gene impacts
on neuronal function and survival remain obscure (Cookson,
2010). We find a role for LRRK at the synapse, and our work
now provides evidence that EndoA is a direct target of LRRK2
kinase activity. LRRK2 mutations cause late onset (>50 years
of age) PD (Paisa´n-Ruı´z et al., 2004; Zimprich et al., 2004) and
this is consistent with the mild defects in neuronal function we
observe in Lrrk mutants or in preparations treated with a selec-
tive LRRK2 inhibitor (LRRK2-IN-1). Furthermore, our data indi-
cate that phosphorylation of EndoA at S75 is not absolutely
essential for synaptic vesicle endocytosis but modulates the
process. From a disease point of view, we demonstrate that
the most frequent genetic mutation associated with PD
LRRK2G2019S (Correia Guedes et al., 2010) increases EndoA
phosphorylation at S75. In agreement with our hypothesis that
both gain and loss of phosphorylation at this site will lead to
functional defects, expression of LRRK2G2019S leads to a
moderate but consistent defect in synaptic recycling. While
the primary goal of our work was to clarify the physiological
role of LRRK/LRRK2 in synaptic function, it is tempting to spec-
ulate that chronic deregulation of such a relative mild mecha-
nism caused by either gain or loss of function of LRRK2 might
underlie a slowly progressing and age-dependent diseaseNeusuch as PD. Kinase activating LRRK2 mutations but also
numerous LRRK2 mutations of which the molecular effect
remains unexplained have been implicated in PD (Greggio and
Cookson, 2009). Our work indicates that both excessive phos-
phorylation and an inability to phosphorylate EndoA at S75
impede synaptic endocytosis, suggesting that deregulation of
LRRK2 in different ways may all result in similar reduced endo-
cytic function. Interestingly, recent data from endoA knockout
mice indicate that loss of the gene causes neurodegeneration
(Milosevic et al., 2011), further linking the LRRK2-induced
defects at the level of EndoA to a neurodegenerative disorder
like PD. Our data also lead to the important conclusion that
both gain and loss of LRRK2 activity has to be taken into consid-
eration when developing LRRK2 as a drug target for PD, and
careful titration of LRRK2 inhibitors might be needed to find
a therapeutic window.
EXPERIMENTAL PROCEDURES
Drosophila Genetics
LrrkP1[e03680] and LrrkEX2mutants were gifted by Jongkyeong Chung (KAIST)
(Lee et al., 2007). Controls were w1118, unless otherwise indicated.
Other alleles were the following:w; endoAD4 (Verstreken et al., 2002),w chc1
(Bazinet et al., 1993), w; dap160D2 (Koh et al., 2004), lap1 (Zhang et al., 1998),
yw; eps15e75 (Koh et al., 2007), and w; a-ada1 (Gonza´lez-Gaita´n and Ja¨ckle,
1997). endoA+ in Figure 2 is endo+(21B) (Venken et al., 2008).
Genomic EndoA phosphomutants were generated by chimeric PCR using
endo+(21B) in P(acman) and primers in Table S1. Wild-type endoA, endoA
[S75A], endoA[S75D], and endoA[S75E] were cloned into pStinger using
AscI and PacI. Transgenes were inserted into VK37 on the second chromo-
some at Genetivision.
Flies expressing human LRRK2 (LRRK2WT), LRRK2KD (LRRKD2017A), and
LRRK2G2019S were generated by site-directed mutagenesis using pCDNA3.1
LRRK2V5 and primers in Table S1. These constructs were cloned into
pUAST-attB using XhoI and NotI. Transgenes were inserted into VK22 on
the second chromosome.
Microscopy
FM1-43, electrophysiology, and electron microscopy were performed and the
data quantified as described (Uytterhoeven et al., 2011; Miskiewicz et al.,
2011) and as outlined in the Supplemental Experimental Procedures. Anti-
bodies used were the following: anti-HRP rabbit pAb (1:1,000; Jackson
ImmunoResearch), anti-Dlg4F3 mouse mAb (1:50), anti-GluRIIA8B4D2 mouse
mAb (1:50, DSHB), anti-endophilin Ab-EndoAGP69 guinea pig (1:1,000), and
Alexa-conjugated secondary antibodies (Invitrogen).
Mass Spectrometry
Cold in vitro LRRK2-phosphorylated human EndoA1 was separated by SDS-
PAGE and Coomassie-stained bands were excised and in-gel digested with
trypsin. One part was analyzed by LC-MS/MS using an Orbitrap XLMS (Ghes-
quie`re et al., 2009); a second part was used to isolate phosphopeptides by tita-
nium dioxide beads (GE Healthcare, TiO2 Mag Sepharose). MASCOT generic
files from the LC-MS/MS data were used to search the human Swiss-Prot
database with trypsin as the protease, allowing for one missed cleavage.
Mass tolerance of the precursor ions was set to 10 ppm (with MASCOT’s
C13 option set to 1) and of fragment ions to 0.5 Da. Variable modifications
were as follows: N-acetylation, N-pyroglutamate, oxidation of methionine,
phosphorylation of serine, threonine, and tyrosine and propionamide forma-
tion of cysteine. Only peptides ranked first, and those of which the MASCOT
ion score exceeded the corresponding identity threshold score set at the
99% confidence level were withheld.
A total of four in vitro human EndoA preparations with LRRK2 and four with
LRRK2KD were analyzed by LC-MS/MS, and, for one preparation, an in-gel
N-propionylation step was done (Arnesen et al., 2010).ron 75, 1008–1021, September 20, 2012 ª2012 Elsevier Inc. 1017
Figure 7. S75 Phosphodead and Phosphomimetic EndoA Both Impede Synaptic Vesicle Endocytosis
(A–D) FM1-43 labeling and quantification of intensity in third-instar larval fillets of endoAD4 Drosophila mutants harboring a genomic endoA construct (w;
endoA+/+; endoAD4 in A), a phosphodead EndoA (w; endoA[S75A]/+; endoD4 in B), or phosphomimetic EndoA (w; endo[S75D]/+; endoD4 in C) using a 1 min,
90 mM KCl stimulation protocol, as well as quantification of FM1-43 labeling intensity (D). Similar levels of EndoA transgene expression are documented
in Figure S6. Heterozygous controls do not show defects in FM1-43 dye uptake (data not shown): w1118: 100% ± 8.9%, endo[wt]/+; endoD4/+: 109.1% ± 6.1%,
endo[S75A]/+; endoD4/+: 103%± 6.2%, endo[S75D]/+; endoD4/+: 93.7% ± 7.3%, ANOVA, p > 0.05 (not significant). Error bars represent SEM, n > 3, ANOVA and
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Figure 8. Expression of LRRK2G2019S
Results in Reduced Synaptic Vesicle Endo-
cytosis
(A) Quantification of FM1-43 labeling after a
1 min, 90 mM KCl stimulation protocol in LRRK2-
IN1-treated larval fillets of genetic controls (yw;
da-Gal4/+) or of larvae expressing LRRK2KD
kinase-dead (yw; da-Gal4/LRRK2D2017A) or of
larvae expressing kinase-active LRRK2G2019S
(yw; da-Gal4/LRRK2G2019S). Error bars represent
SEM, n > 9, ANOVA and Dunnett’s post hoc: ns,
***p < 0.001.
(B) Quantification of FM1-43 labeling after a 1 min,
90 mM KCl stimulation protocol in LRRK2-IN1-
treated LRRK2G2019S kinase-active (yw; da-Gal4/
LRRK2G2019S) animals. The concentrations of
LRRK2-IN1 used are indicated in the figures. Error
bars represent SEM, n > 9, ANOVA and Dunnett’s
post hoc: ns, **p < 0.01. Related to Figure S6.
(C and D) Model for LRRK2 action in the regulation
of synaptic vesicle endocytosis. LRRK2 phos-
phorylates EndoA at S75, enabling the protein
to leave the membrane, while dephosphory-
lation of EndoA facilitates membrane binding.
Thus, expression of LRRK2G2019S or EndoA S75
phosphomimetic mutants impede endocytosis
because EndoA does not efficiently associate
with the membrane (C), while Lrrk mutants or
expression of EndoA phosphodead mutant interferes with vesicle recycling because EndoA fails to efficiently leave the membrane (D). Taken together, we
propose that LRRK2 controls an EndoA phosphorylation cycle that facilitates EndoA-dependent synaptic vesicle formation.
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Rabbit EndoA S75 phosphoantibodies were generated at Pickcell against
VKGIphSKLSGQA and affinity purified using the same peptide and the
nonphosphopeptide.
For lambda phosphatase, fly heads were collected on ice and crushed in
lysis buffer (10 mM HEPES, 150 mM NaCl, 1% triton) (pH 7.4) with complete
protease inhibitor (Roche). Lysate was cleared at 10,000 3 g for 10 min and
supernatant incubated with 800 units/100 mg lambda phosphatase for 1 hr
at 30C.
Tubulation and Flotation Assays
GUVs were composed of a 5:2:1:1 molar ratio of brain L-a-phosphatidylcho-
line, L-a-phosphatidylethanolamine, L-a-phosphatidylserine, cholesterol
(Avanti Polar Lipids), and 2mol%DiO (Invitrogen). We dried 1 ml of 1mg/ml lipid
in chloroform at 70C followed by passive rehydration in PBS with 3 ng/ml
EndoA (or mutant EndoA) (van den Bogaart et al., 2007); fly EndoA wasDunnett’s post hoc: *p < 0.05; ***p < 0.001. Scale bar represents 4.5 mm. The dotte
Figure S6.
(E and F) Raw data traces (E) and quantification (F) of neurotransmitter release m
endoAD4, inw; endoA[S75A]/+; endoD4, and inw; endo[S75D]/+; endoD4. EJP amp
15 s, indicating a gradual decline in EJP amplitude over time in the EndoA phosp
endo[S75D]/+; endoD4 in the last 3 min of recording is 82.4% ± 3.5% or 76.6%
phosphomutants are significantly different from the control (ANOVA and Dunnett’
behind recordings from the phosphomutants. EJP amplitudes recorded during
endoA+/+; endoAD4 control and the EndoA phosphomutants (Figure S6) and unloa
in the control and the EndoA phosphomutants (Figure S6).
(G–J) Electron micrographs of control (w; endoA+/+; endoAD4 in G) and EndoA
endoD4 in I and I0 ) boutons that were stimulated using 60mMKCl for 1min prior to
vesicle number (<80 nm diameter) (J). Inset in (H) shows cisternal structures clos
n > 10 profiles from at least 4 animals, t test: ns, ***p < 0.001.
(K) Cumulative probability plots of themEJP amplitudes recorded in 0.5 mMCa2+ i
S75 phosphomutants (w; endoA[S75A]/+; endoD4 and w; endo[S75D]/+; endoD4)
Neuprepared as outlined in the Supplemental Experimental Procedures. Blinded
confocal microscopy was used to determine tubulation (Yoon et al., 2010).
GUVs prepared by electroswelling (data not shown) yielded similar results.
Liposome composition in flotations (Schuette et al., 2004) was identical to
GUVs. We loaded 30 mM lipids in 25 ml HP150 buffer (20 mM HEPES [pH
7.4]; 150 mM KCl) and 3% (w/v) Na-cholate on a sephadex-G50 (Sigma-
Aldrich) column. We formed 35-nm-sized liposomes by size exclusion cho-
matography (van den Bogaart et al., 2010). Liposome concentration was
240 nM (by FCS; Cypionka et al., 2009). We mixed 750 nM EndoA with two
volumes of liposome suspension and 40% (w/v) nycodenz (Axis-Shield; also
in HP150), overlaid with 30% (w/v) nycodenz and HP150, and centrifuged
for 3 hr at 259,000 3 g in a swinging bucket. We retrieved 20 ml fractions for
western blotting.
LRRK2 phosphorylation in the presence of liposomes was prepared in
kinase buffer (50 mM Tris [pH 7.5], 1 mM EGTA, 10 mM MgCl2, 2 mM
DTT; no detergents) and 2 mM total lipids with 250 nM EndoA wered line indicates FM1-43 uptake in LrrkP1mutants (shown in Figure 1). Related to
easured in 2 mM calcium during 10 min of 10 Hz stimulation in w; endoA+/+;
litudes are binned per 30 s and normalized to the average amplitude of the first
homutants. The average EJP amplitude in w; endoA[S75A]/+; endoD4 or in w;
± 5.2% of that measured in w; endoA+/+; endoAD4 controls and both EndoA
s post hoc: p < 0.001). In (E), data from w; endoA+/+; endoAD4 is shown in gray
low-frequency stimulation (1 Hz) in 2 mM calcium are similar between w;
ding of FM1-43 during a 1 min, 90 mM KCl stimulation paradigm is also similar
S75 phosphomutant (w; endoA[S75A]/+; endoD4 in H; and w; endo[S75D]/+;
fixation and quantification of cisternal number (>80 nm diameter) (J) or synaptic
e to the membrane. Scale bar represents 250 nm. Error bars represent SEM,
n the presence of TTX at the NMJ of control (w; endoA+/+; endoAD4) and EndoA
and mEJP sample traces. n > 8 animals, t test: *p < 0.05. Related to Figure S6.
ron 75, 1008–1021, September 20, 2012 ª2012 Elsevier Inc. 1019
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LRRK2 Phosphorylates EndoA in Endocytosispreincubated and then mixed with 1 ng/ml LRRK2G2019S or kinase-dead
LRRK2KD (LRRK2D1994A) and 200 mM ATP for 2 hr at 37C. This reaction was
mixed with nycodenz and centrifuged.
Western Blotting
Fly heads collected on icewere crushed in lysis buffer (10mMHEPES, 150mM
NaCl, 1% triton) (pH 7.4) with complete protease (Roche) and phosphatase
inhibitor cocktail 2 and 3 (Sigma) followed by clearing at 10,000 3 g for
10 min. Proteins separated on Bis-Tris 4%–12% precast gels (Life Technolo-
gies) were transferred to nitrocellulose. Primary antibodies were the following:
Ab-EndoAGP69 guinea pig (1:5,000); Ab-EndoAS75 rabbit (1:200); Ab-NsybR29
rat (1:2,000); anti-ATPA1 (Novus Biologicals); anti-Flag M2 (Sigma); and anti-
alpha Tubulin (1:2,000).
In Vitro and Cellular Phosphorylation
Recombinant LRRK2 (5 ng LRRK2, LRRK2G2019S, or kinase-dead LRRK2KD
[LRRK2D1994A]; Life Technologies), Drosophila LRRK (Supplemental Experi-
mental Procedures) and 50 ng human EndoA1-3 (SH3GL1, SH3GL2 [Origene];
SH3GL3 [Abnova]), or Drosophila EndoA were incubated in kinase buffer (Tris
50 mM [pH 7.5]; EGTA 1 mM; MgCl2 10 mM; DTT 2 mM; Tween 0.01%) with
1 mM ATP and 1 mCi AT33P (Perkin Elmer) at 37C. SDS PAGE sample buffer
stopped the reactions. EndoA or EndoA1 phosphorylation (Typhoon, Amer-
sham, GE Healthcare) and total protein (colloidal gold, Aurodye, Biorad)
were quantified.
We transfected 500,000 CHO cells/well with V5-tagged LRRK2 with or
without Flag-tagged EndoA1 (Origene). CHO cells expressing scrambled
shRNA or LRRK2 shRNA were transfected with vector or Flag-tagged EndoA1
in the presence or absence of LRRK2 BacMam (LRRK2, LRRK2G2019S, or
LRRK2KD [LRRK2D1994A]; Life Technologies). After 24 hr, cells were incubated
for 2 hr in phosphate-free medium (MP Biomedicals). Intracellular ATP was
labeled by 33P orthophosphoric acid (400 mCi/well) (Perkin Elmer) in phos-
phate-free medium. Washed and lysed cells (1 min sonication) were
centrifuged (10 min at 10,000 3 g) and supernatant was precleared (Dyna-
beads, Invitrogen). EndoA was immunoprecipitated using anti-Flag antibodies
(Sigma) and analyzed on 4%–12% SDS-PAGE using phosphoimaging
(Typhoon, GE Healthcare).
Fractionations
We collected 150 fly heads or 500,000 cells on ice and homogenized
(1,000 rpm) them in STE (5 mM Tris, 250 mM sucrose, 1 mM EGTA) (pH 7.4)
with complete protease (Roche) and phosphatase inhibitor cocktail 2 and 3
(Sigma). Lysate was centrifuged (10 min at 1,0003 g) and supernatant centri-
fuged at 55,0003 g for 1 hr. Supernatant (cytoplasm) was collected and pellet
(membranes) were dissolved in STEwith 0.5% triton. Equal amounts of protein
from each fraction were analyzed by western blotting.SUPPLEMENTAL INFORMATION
Supplemental Information includes six figures, one table, and Supplemental
Experimental Procedures and can be found with this article online at http://
dx.doi.org/10.1016/j.neuron.2012.08.022.
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